Rapid Dose Therapeutics Reports Quarterly Financial Results for First Three Quarters of the 2023 Fiscal Year
BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (RDT or the Company) (CSE: DOSE), has filed its financial results for the first three quarters of the 2023 fiscal year.
Now that t…